Profil
Ritu Shah is Chief Executive Officer at ClostraBio, Inc. since 2022.
Ms. Shah is Advisory Board Member at Portal Innovations LLC starting in 2026.
Former roles include Vice President-Program Management at Novartis Gene Therapies, Inc. from 2017 to 2018, VP-Business Operations & Program Management at Levo Therapeutics, Inc. from 2018 to 2021, and Chief Operating Officer at Pyxis Oncology, Inc. Education includes an undergraduate degree from the University of Notre Dame.
Postes actifs de Ritu Shah
| Sociétés | Poste | Début |
|---|---|---|
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology Develops microbiome-modulating therapeutics | Directeur Général | 01/12/2022 |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Consultant / Advisor | 01/01/2026 |
Anciens postes connus de Ritu Shah
| Sociétés | Poste | Fin |
|---|---|---|
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Corporate Officer/Principal | 01/03/2021 |
| AVEXIS INC | Corporate Officer/Principal | 01/07/2018 |
| PYXIS ONCOLOGY, INC. | Directeur des opérations | - |
Formation de Ritu Shah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Health Technology |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology Develops microbiome-modulating therapeutics | Health Technology |
Pyxis Oncology, Inc.
Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Finance |
















